1. Home
  2. EVGO vs OABI Comparison

EVGO vs OABI Comparison

Compare EVGO & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EVgo Inc.

EVGO

EVgo Inc.

HOLD

Current Price

$1.59

Market Cap

249.7M

ML Signal

HOLD

Logo OmniAb Inc.

OABI

OmniAb Inc.

HOLD

Current Price

$3.38

Market Cap

294.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVGO
OABI
Founded
2010
2012
Country
United States
United States
Employees
376
89
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
249.7M
294.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EVGO
OABI
Price
$1.59
$3.38
Analyst Decision
Buy
Strong Buy
Analyst Count
8
2
Target Price
$5.23
$4.50
AVG Volume (30 Days)
3.6M
458.9K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.45
$52.42
Revenue Next Year
$29.44
$64.69
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.41
$1.32
52 Week High
$5.18
$3.12

Technical Indicators

Market Signals
Indicator
EVGO
OABI
Relative Strength Index (RSI) 45.26 83.44
Support Level $1.41 $1.84
Resistance Level $2.30 N/A
Average True Range (ATR) 0.12 0.18
MACD 0.01 0.13
Stochastic Oscillator 48.61 95.70

Price Performance

Historical Comparison
EVGO
OABI

About EVGO EVgo Inc.

EVgo Inc is an EV fast charging provider. The company deploys charging infrastructure by partnering with retailers, grocery stores, restaurants, gas stations, rideshare operators, and autonomous vehicle companies across the U.S., and serves the EV commercial segment by deploying fleet-charging solutions for light-duty EV fleets at depot locations, off-site charging hubs, or through its public network. It also owns PlugShare, a platform for EV drivers to locate public charging stations, plan trips and share charging experiences, which also provides charging location data licensing, infrastructure analysis, and EV driver research. It also derives revenue from the sale of regulatory credits earned from participation in LCFS programs and other carbon or emissions trading schemes in the U.S.

About OABI OmniAb Inc.

OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.

Share on Social Networks: